These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 37479588)
1. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan. Chen WY; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ Schizophr Res; 2024 Jun; 268():150-160. PubMed ID: 37479588 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia. Huang CY; Fang SC; Shao YJ JAMA Netw Open; 2021 May; 4(5):e218810. PubMed ID: 33974056 [TBL] [Abstract][Full Text] [Related]
3. Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study. Chen PH; Tsai SY; Chen PY; Pan CH; Su SS; Chen CC; Kuo CJ Br J Psychiatry; 2024 Aug; 225(2):328-336. PubMed ID: 38751180 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. Kelly DL; McMahon RP; Liu F; Love RC; Wehring HJ; Shim JC; Warren KR; Conley RR J Clin Psychiatry; 2010 Mar; 71(3):304-11. PubMed ID: 20079332 [TBL] [Abstract][Full Text] [Related]
5. Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia. Wimberley T; MacCabe JH; Laursen TM; Sørensen HJ; Astrup A; Horsdal HT; Gasse C; Støvring H Am J Psychiatry; 2017 Oct; 174(10):990-998. PubMed ID: 28750580 [TBL] [Abstract][Full Text] [Related]
6. Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study. Rose E; Chen S; Turrion C; Jenkins C; Cardinal RN; Fernandez-Egea E Eur Neuropsychopharmacol; 2020 Jul; 36():160-166. PubMed ID: 32546415 [TBL] [Abstract][Full Text] [Related]
7. Mortality in current and former users of clozapine. Walker AM; Lanza LL; Arellano F; Rothman KJ Epidemiology; 1997 Nov; 8(6):671-7. PubMed ID: 9345668 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland. Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224 [TBL] [Abstract][Full Text] [Related]
9. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. De Hert M; Correll CU; Cohen D Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684 [TBL] [Abstract][Full Text] [Related]
10. Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study. Cho J; Hayes RD; Jewell A; Kadra G; Shetty H; MacCabe JH; Downs J Acta Psychiatr Scand; 2019 Mar; 139(3):237-247. PubMed ID: 30478891 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia. Liu HC; Hung GC; Yang SY; Liao YT; Pan CH; Chen CC; Kuo CJ Psychiatry Clin Neurosci; 2018 Oct; 72(10):789-800. PubMed ID: 29987915 [TBL] [Abstract][Full Text] [Related]
12. Impact of clozapine on completed suicide. Sernyak MJ; Desai R; Stolar M; Rosenheck R Am J Psychiatry; 2001 Jun; 158(6):931-7. PubMed ID: 11384902 [TBL] [Abstract][Full Text] [Related]
13. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study. Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551 [TBL] [Abstract][Full Text] [Related]
15. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447 [TBL] [Abstract][Full Text] [Related]
16. Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study. van der Zalm Y; Foldager L; Termorshuizen F; Sommer IE; Nielsen J; Selten JP Acta Psychiatr Scand; 2021 Mar; 143(3):216-226. PubMed ID: 33306211 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia. Taipale H; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J Schizophr Bull; 2021 Jan; 47(1):23-30. PubMed ID: 33428766 [TBL] [Abstract][Full Text] [Related]
18. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia. Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216 [TBL] [Abstract][Full Text] [Related]
19. Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study. Ringbäck Weitoft G; Berglund M; Lindström EA; Nilsson M; Salmi P; Rosén M Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):290-8. PubMed ID: 24435842 [TBL] [Abstract][Full Text] [Related]
20. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]